Biotransformation of chlorpromazine and methdilazine by Cunninghamella elegans

Applied and Environmental Microbiology

Volumn 62, Issue 3, 1996, Pages 798-803

  Zhang, Donglu ^a   Freeman, James P ^a   Sutherland, John B ^a   Walker, Alan E ^a   Yang, Yifan ^a   Cerniglia, Carl E ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYMETHDILAZINE; 3 HYDROXYMETHDILAZINE; 7 HYDROXYCHLORPROMAZINE SULFOXIDE; 7 HYDROXYNORCHLORPROMAZINE; CHLORPROMAZINE; CHLORPROMAZINE N OXIDE; CHLORPROMAZINE SULFOXIDE; CYTOCHROME P450 INHIBITOR; DRUG METABOLITE; ENZYME INHIBITOR; METHDILAZINE; METHDILAZINE N OXIDE; METHDILAZINE SULFOXIDE; METYRAPONE; NORCHLORPROMAZINE; OXYGEN; PHENOTHIAZINE; PROADIFEN; UNCLASSIFIED DRUG;

ARTICLE; BIOTRANSFORMATION; DRUG HYDROXYLATION; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; ULTRAVIOLET SPECTROSCOPY; ZYGOMYCETES;

ANIMALIA; CUNNINGHAMELLA ELEGANS; FUNGI; MAMMALIA; ZYGOMYCETES;

EID: 0029863975     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/aem.62.3.798-803.1996     Document Type: Article

References (29)

1. Alfredsson, G., F. A. Wiesel, and P. Skett. 1977 Levels of chlorpromazine and its active metabolites in rat brain and the relationship to central monoamine metabolism and prolactin secretion. Psychopharmacology 53:13-18
2. Bosch, E., and J. K. Kochi. 1995. Catalytic oxidation of chlorpromazine and related phenothiazines. Cation radicals as the reactive intermediates in sulfoxide formation. J Chem. Soc. Perkin Trans. 1:1057-1064.
3. Cerniglia, C. E. 1984. Microbial metabolism of polycyclic aromatic hydrocarbons Adv. Appl. Microbiol. 30:31-71.
4. Cerniglia, C. E., and D. T. Gibson. 1978 Metabolism of naphthalene by cell extracts of Cunninghamella elegans. Arch. Biochem. Biophys. 186:121-127
5. Chakrabarty, A. N., C. P. Bhattacharya, and S. G. Dastidar. 1993. Antimycobacterial activity of methdilazine, an antimicrobial phenothiazine. APMIS 101:449-454.
6. Chattopadhyay, D., S. G. Dastidar, and A. N. Chakrabarty. 1988. Antimicrobial properties of methdilazine and its synergism with antibiotics and some chemotherapeutic agents. Arzneimittel-Forschung 38:869-872.
7. Clark, A. M., and C. D. Hufford. 1991. Use of microorganisms for the study of drug metabolism an update. Med. Res. Rev 11:473-501.
8. Coccia, P. F., and W. W. Westerfeld. 1967. The metabolism of chlorpromazine by liver microsomal enzyme systems. J Pharmacol Exp Ther. 157: 446-458.
9. Davis, P. J. 1988. Microbial models of mammalian drug metabolism Dev. Ind. Microbiol 29:197-219.
10. Ferris, J. P., L. H. MacDonald, M. A. Patrie, and M. A. Martin. 1976. Aryl hydrocarbon hydroxylase activity in the fungus Cunninghamella bainieri. evidence for the presence of cytochrome P-450 Arch. Biochem. Biophys. 175: 443-452.
11. Gibson, M., C. J. Soper, R. T. Parfitt, and G. J. Sewell. 1984. Studies on the mechanism of microbial N-demethylation of codeine by cell-free extracts of Cunninghamella bainien. Enzyme Microb Technol. 6:471-475.
12. Gilman, A. G., L. S. Goodman, T. W. Rall, and F. Murad. 1985. Drugs and the treatment of psychiatric disorders, p. 387-412. In A. G. Gilman and L S. Goodman (ed.), Goodman and Gilman's the pharmacological basis of therapeutics, 7th ed. Macmillan Publishing Company, New York.
13. Goldenberg, H., and V. Fishman. 1964. Metabolism of chlorpromazine. Confirmation of position 7 as the major site of hydroxylation. Biochem. Biophys. Res. Commun. 14:404-407.
14. Gorrod, J. W., C. R. Lazarus, and A. H. Beckett. 1972. Inhibition of the alternative pathways of chlorpromazine metabolism in vitro Biochem. J. 130: 13p.
15. Guengerich, F. P., and T. L. MacDonald. 1990. Mechanisms of cytochrome P450 catalysis. FASEB J. 4:2453-2459.
16. Hartmann, F., L. D. Gruenke, J. C. Craig, and D. M. Bisseli. 1983. Chlorpromazine metabolism in extracts of liver and small intestine from guinea pig and from man. Drug Metab. Dispos. 11:244-248.
17. Kadlubar, F. F., and G. J. Hammons. 1987. The role of cytochrome P-450 in the metabolism of chemical carcinogens. p 81-130. In F. P Guengerich (ed.). Mammalian cytochrome P450, vol. II. CRC Press, Inc , Boca Raton, Fla.
18. Korfmacher, W. A., C. L. Holder, C. E. Cerniglia, D. W. Miller, E. B. Hansen, Jr., K. L. Lambert, A. B. Gosnell, W. Slikker, Jr., L. G. Rushing, and H. C. Thompson, Jr. 1985. Desorption chemical ionization mass spectrometry of nine antihistamines and some of their metabolites. Spectrosc Int. J. 4:181-192.
19. Morselli, P. L. 1977. Psychotropic drugs, p 431-474. In P. L. Morselli (ed.), Drug deposition during development. Spectrum Publications, New York.
20. Omura, T., and R. Sato. 1964 The carbon monoxide-binding pigment of liver microsomes. J. Biol. Chem. 239:2370-2378.
21. Robinson, A. E. 1966. Biotransformation in vitro undergone by phenothiazine derivatives in a liver preparation. J. Pharm. Pharmacol. 18:19-32.
22. Schlenk, D., R. J. Bever, A. M. Vertino, and C. E. Cerniglia. 1994. P450 catalysed S-oxidation of dibenzothiophene by Cunninghamella elegans. Xenobiotica 24:1077-1083.
23. Smith, R. V., and J. P. Rosazza. 1982 Microbial transformations as means of preparing mammalian drug metabolites, p. 1-42. In J. P. Rosazza (ed.), Microbial transformation of bioactive compounds, vol. II. CRC Press, Inc., Boca Raton, Fla.
24. Sutherland, J. B., F. Rafii, A. A. Khan, and C. E. Cerniglia. 1995. Mechanisms of polycyclic aromatic hydrocarbon degradation, p. 269-306. In L. Y. Young and C. E. Cerniglia (ed.), Microbial transformation and degradation of toxic organic chemicals. Wiley-Liss, New York.
25. Traficante, L. J., J. Siekierski, G. Sakalis, and S. Gershon. 1979. Sulfoxidation of chlorpromazine and thioridazine by bovine liver-preferential metabolic pathways. Biochem. Pharmacol. 28:621-626.
26. Usdin, E. 1971. The assay of chlorpromazine and metabolites in blood, urine, and other tissues. Crit. Rev. Clin. Lab Sci. 2:347-391.
27. Wode-Helgodt, B., and G. Alfredsson. 1981. Concentrations of chlorpromazine and two of its active metabolites in plasma and cerebrospinal fluid of psychotic patients treated with fixed drug doses. Psychopharmacology 73: 55-62.
28. Yang, W., T. Jiang, and P. J. Davis. 1993. Microbial models of mammalian metabolism: involvement of cytochrome P450 in the N-demethylation of N-methylcarbazole by Cunninghamella echinulata. Xenobiotica 23:973-982.
29. Ziegler, D. M. 1988. Flavin-containing monooxygenases: catalytic mechanism and substrate specificities. Drug Metab. Rev. 19:1-32.